Posts Tagged ‘Clinical Trial’

Is This Finally DBT’s Time?

Posted on: May 13th, 2022 by admin 2 Comments

Full-field digital mammography (FFDM) has been the “go to” imaging modality to screen for early detection of breast cancer for […]

ABUS and DBT and FFDM

Posted on: March 18th, 2022 by admin 2 Comments

It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]

Learning from Past Mistakes

Posted on: March 4th, 2022 by admin

Almost 25 years ago, in 1998, the FDA approved computer-aided detection (CAD) tools as an adjunct to mammography. This was before the […]

Efficacy of Breast Self-Exams

Posted on: February 25th, 2022 by admin 2 Comments

It is widely accepted that when breast cancer is diagnosed early and remains localised, effective treatment yields a five-year survival […]

Cape Town Company Develops Covid-19 Test Kit

Posted on: December 10th, 2021 by admin

Five years ago, CapeRay joined a consortium of local manufacturers to establish a not-for-profit company called the Western Cape Medical Devices […]

Evaluating DBT after 10 Years

Posted on: December 3rd, 2021 by admin

Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]

What if it’s not Randomized?

Posted on: November 26th, 2021 by admin

The National Cancer Institute in the USA defines a randomized clinical trial as: “A study in which the participants are divided by […]

Benefits of Screening Recognised

Posted on: September 24th, 2021 by admin 2 Comments

The Radiological Society of North America (RSNA) has just announced that the Alexander Margulis Award for Scientific Excellence in 2021 has been […]

Is AI Ready for Breast Screening?

Posted on: September 10th, 2021 by admin 1 Comment

Judging by their marketing, companies are gearing up for widespread adoption of their artificial intelligence (AI) algorithms by breast screening […]

Optimising Breast Cancer Screening

Posted on: August 27th, 2021 by admin

Six years ago, we reviewed a paper published in The Lancet by the Japan Strategic Anti-Cancer Randomized Trial (J-START) in which the […]